15/09/2020 – 11:19 | Portfolio

Investment will support continued growth and expansion of leading reference-based pricing platform

HILLSBORO, Ore., Sept. 9, 2020 – 6 Degrees Health, a provider of technology-enabled healthcare cost containment solutions for self-insured employers, today announced it has secured a significant investment from FTV Capital, a sector-focused growth equity investor in innovative companies in enterprise technology and services, financial services, and payments and transaction processing. This investment will enable 6 Degrees Health to expand its platform, which enables employers to realize significant cost savings while also generating best-in-class employee experience.

6 Degrees Health’s reference-based pricing solutions encourage health plans to pay providers a fair rate, without unduly restricting employee benefits. 6 Degrees Health’s proprietary MediVI technology platform collects, analyzes and benchmarks claims and billing data across plans, providers and geographies to provide medical reimbursement analytics for audits, contracting and claim negotiation.

“Our goal at 6 Degrees Health is to bring equity and fairness back into the healthcare reimbursement equation,” said Scott Ray, CEO of 6 Degrees Health. “Through our differentiated, per-employee-per month pricing model and our MediVI technology platform, we look to eliminate restrictive networks, decrease healthcare costs and allow members to seek care from any provider they choose without the risk of decreased benefits. FTV Capital’s investment and strong expertise in enterprise technology will allow us to continue focusing on bringing greater transparency to our customers and the healthcare sector more broadly.”

“As a result of a strong leadership team and passion to provide transparency, 6 Degrees Health continues to ‘pull back the curtain’ on healthcare pricing,” said Alex Mason, partner at FTV Capital. “FTV Capital is excited to partner with a driven, dedicated team to help further enhance its technologies and create more transparency for the market.”

“Rising healthcare spend is a significant cost burden and managing high-cost claims is the top priority for self-insured employers,” said Chris Winship, partner at FTV Capital. “6 Degrees Health provides self-insured employers with a technology-enabled cost-containment solution that delivers significant savings on healthcare claims. We are excited to support the company’s incredible traction as they inject analytics into a challenged industry that is swimming in broken technologies, manual processes and other inefficiencies.”

As part of the transaction, FTV Capital’s Chris Winship, Alex Mason and Abhay Puskoor will join the 6 Degrees Health board of directors.

6 Degrees Health was advised by Covington Associates.

• EQT Infrastructure enters exclusive negotiations to acquire a majority stake in Colisee, a leading European operator of nursing home facilities and home care services agencies in France, Belgium, Spain and Italy
• EQT Infrastructure will support Colisee and the management team, led by Christine Jeandel, with their continued focus on quality and well-being of residents, and growth opportunities in current and new markets
• Colisee constitutes a thematic investment in social infrastructure, a sector where EQT has extensive experience and a proven track record from owning and developing strong companies

EQT today announced that the EQT Infrastructure V fund (“EQT Infrastructure”) has entered exclusive negotiations to acquire a majority stake in Colisee (“Colisee” or the “Company”) owned by IK Investment Partners.

Established in 1976, Colisee is a leading operator of nursing home facilities and homecare services for elderly. The Company, which is headquartered in Paris, France, has developed a geographical footprint and operates 270 nursing homes as well as assisted living facilities and home care services agencies across France, Belgium, Spain and Italy. Colisee employs more than 16,000 people and has a turnover exceeding EUR 1 billion.

Colisee’s long-term development is supported by strong secular trends, such as an aging European population and an increased shift to privately managed elderly care. Colisee’s high focus on care and resident well-being is a key attraction in a sector where EQT Infrastructure has extensive experience.

Following the closing of the transaction, EQT Infrastructure will support the continued development of Colisee and its pursuit of new growth opportunities in current and new markets, drawing on EQT’s global footprint and extensive network of advisors. Moreover, EQT will support Colisee in further developing the Company’s social responsibility and sustainability ambitions.

The investment in Colisee is in line with EQT’s thematic approach guided by the United Nations Sustainable Development Goals, specifically SDG 3, “Good health and well-being” and SDG 11, “Sustainable cities and communities”.

Christine Jeandel, President of Colisee, said: “With the EQT teams, Colisee will continue its development project at the service of elderly people in line with its core values. This move is a great opportunity to continue to position Colisee as sustainable key player in the market, with social responsibility at the heart of its mission.”

Ulrich Köllensperger, Partner at EQT Partners and Investment Advisor to EQT Infrastructure, said: “EQT Infrastructure has followed Colisee for a long time and we are deeply impressed by Christine Jeandel and her management team’s achievements in successfully creating a leading platform in the elderly care sector. Colisee constitutes a truly thematic investment in social infrastructure, a sector where EQT has a proven track record of owning and developing strong companies.”

Thomas Rajzbaum, Managing Director at EQT Partners, Investment Advisor to EQT Infrastructure and Head of EQT’s French Infrastructure Advisory Team, added: “Colisee provides essential services to society and truly makes a positive impact in the communities in which it operates. The Company’s core values and ESG approach are strongly in line with EQT’s and we look forward to continue building on Colisee’s renowned focus on high service quality and well-being for its residents.”

The acquisition of Colisee is EQT’s first investment in France following the opening of the Paris office in June 2020, and EQT Infrastructure’s second investment after the French water services management company SAUR.

The transaction is subject to the consultation process or information of the Employee Representative Bodies, as well as antitrust and potential foreign investment clearances.

With the acquisition of Colisee, EQT Infrastructure V will be 5-10 percent invested based on its target fund size. No decision has been made to date regarding the termination of the commitment period of EQT Infrastructure IV and the first fee date of EQT Infrastructure V.

Contact
For French media inquiries, Benoit Grange, Brunswick Paris, +33 614 450 926
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334
PLEAD, Julien Tahmissian, Julien.tahmissian@plead.fr, + 33 7 88 35 98 90

About EQT
EQT is a differentiated global investment organization with more than EUR 62 billion in raised capital and around EUR 40 billion in assets under management across 19 active funds. EQT funds have portfolio companies in Europe, Asia-Pacific and North America with total sales of more than EUR 27 billion and approximately 159,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, Twitter, YouTube and Instagram

About Colisee
Colisee is a key player in the global health care and old-age dependency sector and has developed a real expertise in elderly people care and well-being. Its network includes more than 270 facilities in France, Belgium, Spain and Italy. Colisee employs more than 16,000 people.

More info: www.groupecolisee.com/en

New investment will expand care delivery platform solutions and enable deeper healthcare provider partnerships  

BOSTON – Aug 11, 2020 – Lumeon, the leader in care pathway orchestration, today announced that it has closed $30M in Series D funding led by new investors Optum Ventures and Endeavour Vision, with participation from current investors LSP, MTIP, IPF Partners, Gilde and Amadeus Capital Partners. The investment will enable the company to extend the reach of its Care Pathway Management (CPM) platform, which helps healthcare providers automate their patient care coordination to improve care quality, deliver better outcomes and reduce costs.

Lumeon’s CPM platform uses real-time data to dynamically guide patients and care teams along their care journeys. By automating, orchestrating and virtualizing care delivery across care settings, Lumeon’s solutions allow health systems to operate with predictability and efficiency, delivering optimal care to each patient while substantially lowering costs for healthcare providers.

“While the markets for data analytics, clinical decision support and patient engagement are well established, what is missing today is the ability to effectively connect them to solve the problem of personalizing care delivery in a scalable way,” said Lumeon Founder and CEO Robbie Hughes. “The ‘last mile’ that turns the insight into action is the hardest part for health systems, and is the core of the Lumeon proposition.”

Hughes continued, “This investment will allow us to continue on our rapid growth path, as we help healthcare systems develop and scale new models of delivery.”

“As the technology-driven transformation of healthcare is accelerated by COVID-19, Lumeon’s ability to optimize the care of every patient based on individual risk, cost, engagement and social determinants is crucial for their customers to operate effectively,” said Optum Ventures Principal Dr. Ashish Patel. “We believe Lumeon is uniquely positioned to help health systems unlock new opportunities in sustainable, profitable care delivery.”

Lumeon’s CPM platform integrates with all electronic health record (EHR) systems in addition to incorporating required clinical and administrative data from point solutions and devices, addressing the fragmented nature of healthcare technology and the challenge of interoperability. By extending beyond the confines of a healthcare provider’s EHR, Lumeon’s configurable solutions maximize current investments as organizations evolve their care delivery models.

“Lumeon’s flexible CPM platform offers an unparalleled solution to the care pathway challenges many health systems face,” said Alexander Schmitz, Partner at Endeavour Vision. “By coordinating processes across the continuum – from basic administrative tasks through to highly complex clinical optimization protocols – Lumeon is helping to define a new future for patient care.”

About Lumeon

Lumeon helps health systems take control of their care delivery processes by orchestrating and automating care journeys to operate with predictability and efficiency.

Its industry-leading solutions act as the ‘auto-pilot’ for healthcare delivery, navigating the patient care journey while coordinating care teams, communication, tasks, and decisions to increase revenue, optimize resource utilization, and deliver superior outcomes at less cost.

Lumeon’s solutions are enabled by their cloud-based care pathway management (CPM) platform. Capitalizing on the patient’s electronic health record (EHR), health systems can start simply with immediate benefits and evolve to orchestrate their entire care process.

More than 70 progressive health systems across 12 countries have deployed Lumeon’s multi-award-winning platform. www.lumeon.com

For further information, contact:

Hanah Johnson

March Communications

lumeon@marchcomms.com

617-960-8892

Kinnevik AB (publ) (“Kinnevik”) today announced that it supports the proposed merger between Teladoc Health, Inc. (NYSE: TDOC) (“Teladoc Health”), the global leader in virtual care, and Livongo Health, Inc. (Nasdaq: LVGO) (“Livongo”), the leading Applied Health Signals company, creating the only consumer centered virtual care platform for a full spectrum of health needs. When the merger has been completed, Kinnevik will become an owner of a 4.5 percent stake in the combined company and receive USD 143m (SEK 1.3bn) in cash consideration. The merger consideration values Kinnevik’s stake in Livongo at approximately USD 2.0bn (SEK 17.6bn), up USD 183m (SEK 1.6bn) from the value of Kinnevik’s stake in Livongo at 4 August 2020 close.

As announced today by Teladoc Health and Livongo, the companies have entered into an agreement to merge. Under the terms of the agreement, supported by the Boards of Directors of both Teladoc Health and Livongo, each share of Livongo will be exchanged for 0.592 Teladoc Health shares and USD 11.33 in cash, in total representing a value of USD 158.98 per Livongo share, based on the closing price of Teladoc Health on 4 August 2020. The value ascribed to Livongo in the merger represents a premium of approximately 56 percent to Livongo’ 30-day volume-weighted average price and a premium of 10 percent to the closing price of Livongo on 4 August 2020.

The transaction is expected to close by the end of Q4 2020, subject to regulatory approval, Teladoc Health and Livongo shareholder approvals, and other customary closing conditions.

Kinnevik is today the second largest shareholder in Livongo, holding 13 percent of outstanding shares corresponding to 11 percent on a fully diluted basis. When the merger has been completed, Kinnevik will receive USD 143m (SEK 1.3bn) in cash and approximately 7.5 million shares in the combined company, corresponding to a 4.5 percent economic stake on a fully diluted basis. The merger consideration values Kinnevik’s stake in Livongo at approximately USD 2.0bn (SEK 17.6bn) in total, based on the closing price of Teladoc Health on 4 August 2020. Kinnevik supports the proposed merger, and has undertaken to vote in favor of the merger at an upcoming general meeting of Livongo shareholders, and to retain the main portion of its stake in Livongo until completion of the merger, subject to disposals according to customary conditions.

The combination joins two highly complementary companies to create an unmatched, comprehensive platform for virtual healthcare delivery. By bringing together leaders in virtual health and chronic condition management, the merger combines:

• Comprehensive clinical expertise with a rich technology and data-driven experience
• Prevention and chronic condition management with acute and specialty care
• Behavior change expertise with data science
• Global footprint with products meeting a global need
• Access with innovation
• Two of the fastest growing companies in health technology

The combined company will have expected 2020 pro forma revenue of approximately USD 1.3bn, representing year-over-year pro forma growth of 85 percent, and pro forma adjusted EBITDA of over USD 120m. The combined company is positioned to execute quantified opportunities to drive revenue synergies of USD 100m by the end of the second year follow completion, reaching USD 500m on a run rate basis by 2025. These opportunities include increased cross-selling and penetration into each company’s client base, accelerating Livongo’s international expansion through Teladoc Health’s existing footprint, improving member retention rates and driving more efficient enrollment.

Almost five years ago, Kinnevik put in place a strategy to apply its learnings from consumer-centric and technology-enabled transformation of other sectors to healthcare. We sought to leverage technology, data science and clinical innovation to yield better, more accessible and lower cost care. Livongo was our second investment as part of this strategy, with the vision to create a whole person platform to empower people with chronic conditions to live better and healthier lives. Today, Kinnevik’s portfolio of digital health companies also includes Babylon, Cedar, Cityblock and VillageMD. The proposed transaction is a testament to the value of Livongo’s platform and validates Kinnevik’s healthcare investment strategy. In total, Kinnevik has invested SEK 3.5bn into its digital healthcare businesses, generating an exceptional 6.6x return on our total investment and an unrealized internal rate of return of over 150 percent, including the value of the proposed merger consideration.

Kinnevik’s CEO Georgi Ganev commented: “Since our first investment in Livongo in 2017, Glen Tullman and his team have consistently impressed us with their vision and execution building a global leader in chronic care management. We were proud to support and invest in the IPO last year, and since then Livongo’s success has accelerated as the relevance of its customer proposition has become ever stronger, fueling exceptional growth and profitability. With the proposed merger, Kinnevik recoups almost our entire invested capital in Livongo in cash, and becomes a significant shareholder in the only consumer centered virtual care platform for a full spectrum of health needs. We therefore benefit from continued long-term upside as the combined company is positioned to serve an even larger addressable market with a truly unparallelled offering.”

For further information about the details and preliminary timetable of the merger and the combined company, please refer to the press releases issued by Teladoc Health at www.teladochealth.com and Livongo at www.livongo.com, as well as the joint transaction website at www.teladochealthlivongo.transactionannouncement.com.

This information is information that Kinnevik AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 12.10 CET on 5 August 2020.

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.